Oliver Steinbach, PhD (Vice President of Clinical and Regulatory...

Oliver Steinbach, PhD (Vice President of Clinical and Regulatory Affairs)

So……Dr. Steinbach was appointed in February 2020 to lead the development and execution of Imagion Biosystems’ overall clinical and regulatory strategy, focusing in the near-term on initiating a first-in-human study for HER2 metastatic breast cancer.

Now….oliver has gone and dr jaya has been appointed, for essentially the same role but a more elevated title.

Did Oliver stuff up and get marched, or, is there an issue at IBX and he decided it was time to move onto bigger and better things?

These are pretty significant staff movements for a biotech company. I’m sure there is a bit more to this story.